 |
|
|
|
 |
 |
 |
|
|
 |
|
Activation
|
|
 |
Plasma Based Solutions:
|
 |
Improve cell and biomaterial adhesion to clinical diagnostic platforms.
Platforms for immuno assays, cell culture media and other clinical diagnostic substrates are pre-dominantly fabricated from synthetic polymers. While such materials are ideally inert, mechanically stable, and low cost for this industry, their surface properties have inherent limitations. Specifically, they have inadequate binding sites for cells and bio-active molecules to anchor effectively to their surfaces. Strong, and uniformly dispersed binding sites are an important prerequisite for the immobilization of bio materials, and for in vitro cell cultivation. For synthetic polymer platforms to improve their properties for cell proliferation and biomolecular adsorption, they must be surface modified. PVA TePla has long been providing a service for the plasma activation of immuno assay and cell culture media for manufacturers of clinical diagnostic substrates.

Related Products:
|
M4L |
7200 |
Plasma Pen |
Robo Pen |
 |
 |
 |
 |
To Request Application Literature or Further Information, Click Here |

|
|
| |
What is Plasma? |
 |
| |
| |
Why
RF Plasma? |
| |
 |
| |
| |
Why
Atmospheric Plasma? |
| |

|
|
|
 |
|
|
 |
 |
 |
 |
 |
|